Advances in three key areas are leading to a paradigm shift in type 1 diabetes treatment and research, according to a speaker ...

Within the medical ecosystem, health guidelines aim for timely diagnosis and regular follow-up of chronic illnesses, such as ...

The results come as Dexcom is awaiting a decision from the Centers for Medicare and Medicaid Services to expand Medicare ...

People receiving AI-supported screening for diabetic retinopathy, a leading cause of blindness globally, were almost twice as ...

Users had a lower HbA1c level and spent 5 more hours in target range ...

Discover the top nutritional resources of 2026 for people with diabetes, featuring expert advice, meal planning tools, and ...

Experts say GLP-1 drugs are just one part of diabetes care. Adding a continuous glucose monitor improves results.

Treatment with glucagon-like peptide-1 receptor agonists (GLP-1s) was associated with lower risks of psychiatric ...

If you look at the tubeless market, you know, we're seeing growth rates in excess of 25% annually,” Tandem Diabetes CEO John Sheridan explains to Bloomberg Intelligence about the growth opportunities ...

A simple timed walking test may be feasible among patients with type 2 diabetes attending a primary care clinic, with mean ...

If you’ve experienced any of these, you should really consider talking to your doctor.